POET: Protocol Optimization via Eligibility Tuning
Trisha Das, Katherine Kero, Dorinda Schumann, Tracy Ohrt, Sanjit Singh Batra, Gregory D Lyng, Robert E. Tillman
TL;DR
POET tackles the bottleneck in clinical trial design by enabling interpretable eligibility criteria (EC) generation through semantic axes guided by large language models. It frames EC generation as a masked, axis-constrained prediction problem, complemented by a data-driven masking strategy and a rubric-based evaluation that includes LLM-based judgments aligned with clinicians. Empirical results show guided generation consistently outperforms unguided generation across rarity levels and correlates with clinician assessments, supporting scalable, interpretable AI-assisted trial design. The framework demonstrates a practical path toward reducing clinician burden while improving EC quality and consistency in real-world trial design workflows.
Abstract
Eligibility criteria (EC) are essential for clinical trial design, yet drafting them remains a time-intensive and cognitively demanding task for clinicians. Existing automated approaches often fall at two extremes either requiring highly structured inputs, such as predefined entities to generate specific criteria, or relying on end-to-end systems that produce full eligibility criteria from minimal input such as trial descriptions limiting their practical utility. In this work, we propose a guided generation framework that introduces interpretable semantic axes, such as Demographics, Laboratory Parameters, and Behavioral Factors, to steer EC generation. These axes, derived using large language models, offer a middle ground between specificity and usability, enabling clinicians to guide generation without specifying exact entities. In addition, we present a reusable rubric-based evaluation framework that assesses generated criteria along clinically meaningful dimensions. Our results show that our guided generation approach consistently outperforms unguided generation in both automatic, rubric-based and clinician evaluations, offering a practical and interpretable solution for AI-assisted trial design.
